New study suggests GLP-1 drugs like Ozempic and Wegovy may raise fracture risk by 11% in adults 65 and older with type 2 ...

New research suggests GLP-1 drugs may increase the risk of bone and tendon injuries and other conditions, including ...

That's according to a new study presented at the American Academy of Orthopedic Surgeons annual meeting.

The appetite-suppressing drugs decrease a person's intake of food and nutrients, which can impact bone health and lead to ...

Fact checked by Nick Blackmer New research suggests prolonged GLP-1 use may be linked to a higher risk of osteoporosis and ...

About 4% of GLP-1 users developed osteoporosis, compared with a little over 3% of nonusers — an increased risk of about 30%. A related condition, osteomalacia, which involves the softening of the ...

People on GLP-1s had slightly higher risks of osteoporosis and gout than similar people not taking these drugs. But diet and ...

A new research study has shed light on potential side effects of GLP-1 drugs, including Wegovy and Ozempic. According to a ...

Results show increased long-term risk for osteoporosis, gout and osteomalacia in one study; improved postoperative outcomes for common orthopaedic procedures in another NEW ORLEANS, March 2, 2026 ...

Sobi, which currently has a drug under FDA review as a later line of therapy for gout, is paying $950 million to acquire Arthrosi Therapeutics, a startup with a gout drug candidate in Phase 3 ...